Anife Tashi Awarded Compensation for Shoulder Injury Related to Vaccine Administration (SIRVA)

Strategic Insights -

Anife Tashi, a petitioner in the National Vaccine Injury Compensation Program, has been awarded compensation for her shoulder injury related to vaccine administration (SIRVA) following an influenza vaccine received on October 15, 2022. The United States Court of Federal Claims ruled in her favor, citing the respondent's concession that Tashi's alleged injury is consistent with SIRVA as defined by the Vaccine Injury Table. The Chief Special Master Corcoran's ruling, filed on July 7, 2025, found that Tashi satisfied all legal prerequisites for compensation under the Act, including suffering residual effects of her condition for more than six months.

Key Takeaways:

  • The National Vaccine Injury Compensation Program has awarded compensation to Anife Tashi for her SIRVA, which occurred after receiving an influenza vaccine on October 15, 2022.
  • The United States Court of Federal Claims ruled in Tashi's favor, citing the respondent's concession that her alleged injury is consistent with SIRVA as defined by the Vaccine Injury Table.
  • Tashi satisfied all legal prerequisites for compensation under the Act, including suffering residual effects of her condition for more than six months.
  • According to 42 U.S.C. § 300aa-11(c)(1)(D)(i), -13(a)(1)(B), Tashi has met the requirements for compensation.
  • The case, No. 24-1748V, was assigned to the Special Processing Unit of the Office of Special Masters.
  • Petitioner has 14 days to identify and move to redact medical or other information from the public ruling.

Statistics:

  • October 15, 2022: Date of influenza vaccine administration
  • October 25, 2024: Date of Tashi's petition for compensation under the Vaccine Act
  • July 3, 2025: Date of Respondent's Rule 4(c) report
  • July 7, 2025: Date of Chief Special Master Corcoran's ruling
  • 14 days: Timeframe for Petitioner to identify and move to redact medical or other information from the public ruling
  • 42 U.S.C. § 300aa-10, et seq.: Provisions of the Vaccine Act
  • 42 U.S.C. § 300aa-11(c)(1)(D)(i), -13(a)(1)(B): Provisions relevant to Tashi's case

Sources:

  • United States Court of Federal Claims
  • 42 U.S.C. § 300aa-10, et seq. (National Childhood Vaccine Injury Act of 1986)
  • 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services)